ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -99.2% | 1,000 | -94.3% | 0.00% | -100.0% |
| Q4 2014 | $118,000 | -2.5% | 17,650 | -18.7% | 0.01% | 0.0% |
| Q3 2014 | $121,000 | -22.4% | 21,700 | +40.7% | 0.01% | -20.0% |
| Q2 2014 | $156,000 | -22.4% | 15,425 | -7.5% | 0.01% | -28.6% |
| Q1 2014 | $201,000 | -6.1% | 16,675 | -12.1% | 0.01% | -12.5% |
| Q4 2013 | $214,000 | +22.3% | 18,975 | +16.6% | 0.02% | +6.7% |
| Q3 2013 | $175,000 | – | 16,275 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |